Indicators and Reagents (Reagents)

Subscribe to Selected New Research on Indicators and Reagents

2190 relevant articles (111 outcomes, 241 trials/studies) found for this Bio-Agent

Description: Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499)

Also Known As:

Reagents; Indicators; Reagents and Indicators

Relationship Network

Bio-Agent Context: Research Results

Chemical Actions and Uses

Specialty Uses of Chemicals

Laboratory Chemicals

Indicators and Reagents: 2190

Thiobarbituric Acid Reactive Substances: 885

Radiopharmaceuticals: 753

Reducing Agents: 180

Intercalating Agents: 62

Sulfhydryl Reagents: 36

Chromogenic Compounds: 16

Cross-Linking Reagents: 11

Affinity Labels: 5

Diagnostic Reagent Kits: 2

Luminescent Agents

Experts

1.	Barker, Peter E: 2 articles (05/2007 - 09/2006)
2.	Srivastava, Sudhir: 2 articles (05/2007 - 09/2006)
3.	Jungbluth, Achim A: 1 article (05/2008)
4.	Calzada, Leobardo: 1 article (01/2008)
5.	Salazar, Edith L: 1 article (01/2008)
6.	Hänninen, Pekka E: 1 article (11/2007)
7.	Soukka, Jori: 1 article (11/2007)
8.	Koskinen, Janne O: 1 article (11/2007)
9.	Meltola, Niko J: 1 article (11/2007)
10.	Vainionpää, Raija: 1 article (11/2007)

Related Diseases

1.	Neoplasms (Cancer) 05/01/1998 - "These reagents will permit improved diagnostics and offer the promise of enhanced therapeutic targets for this cancer. " 05/01/1985 - "Our data suggest that treatment with 4-HC in combination with multiple monoclonal antibody reagents could be a safe and effective method of eliminating clonogenic tumor cells from human bone marrow." 03/01/2009 - "Many cancers are either initially resistant to EGFR inhibitors or become resistant during treatment, limiting the efficacy of these reagents. " 11/01/1993 - "The efficacy of the reagents estimated by the reduction of tumor size and calculated by T/C (%), was 28.3%, 16.4%, 47.8%, and 83.1%, respectively. " 11/01/1993 - "In vivo antitumor efficacy of tumor-draining lymph node cells activated with nonspecific T-cell reagents." Order ALL the reference details at left...
2.	Infection 02/01/2004 - "These mAbs may be very useful in distinguishing between BHV-1 and BHV-5 infections since most of the traditional reagents and techniques are unable to do so. " 11/01/1986 - "The practical efficacy of these reagents and procedures is documented by the ability of maternal immunization with anti-idiotope to confer complete protection in neonates from a potentially lethal reovirus type 3 viral infection." 02/01/2009 - "Better understanding of the molecular basis of viral structural genes involved with production should contribute significantly toward the development of improved prophylactic and therapeutic reagents to control the infection. " 06/01/2005 - "Better understanding of the molecular basis of viral pathogenesis should contribute significantly towards the development of improved prophylactic, therapeutic and diagnostic reagents to control infections. " 05/01/1994 - "The acquisition of these mAbs provide reagents which would be very useful in the development of simple immunodiagnostic assays for the diagnosis of V. cholerae O139 infections." Order ALL the reference details at left...
3.	Hypersensitivity (Allergy) 01/01/2007 - "CONCLUSION: This study describes the production of new reagents to identify eosinophils (as well as granulocytes) in sheep that will be useful in studying the role of eosinophils in disease pathologies in parasite and allergy models." 06/01/2006 - "Previous studies have demonstrated insufficient sensitivity of commercially available cherry extract reagents in the diagnosis of cherry allergy. " 06/01/2005 - "The aim of this study was to evaluate the clinical availability of the lymphocyte stimulation test (LST) using metal reagents as a method for diagnosing metal allergy. " 01/01/2003 - "The reagents described here provide tools for further study of association with clinical and biochemical phenotypes related to allergy and immunity." 01/01/2009 - "From July 2000 to June 2005, 212 patients with suspected dental metal allergy were patch tested with 26 reagents, including 19 ready-made patch test reagents (Patch test reagents, Torii Pharmaceutical Corporation, Tokyo, Japan) and 9 custom-made reagents. " Order ALL the reference details at left...
4.	Tuberculosis 12/01/2001 - "Use of the information gained from sequencing the Mycobacterium tuberculosis genome will enable scientists to accelerate the development of reagents for improved tuberculosis control. " 01/01/2004 - "A decisive role in enhancing the effectiveness of detection of patients with tuberculosis by the Ziel-Nielsen test is played by the following factors: training of laboratory personnel; provision of laboratories with high-grade equipment and reagents; introduction of the methods and techniques unified and approved by the Ministry of Health of the Russian Federation; regular supervision of jurisdictional laboratories; outside control of the quality of studies. " 11/01/2009 - "tuberculosis complex in clinical specimens by TRC-2 with ready-to-use reagents was an efficient and rapid method for the diagnosis of pulmonary and extrapulmonary TB." 01/01/2009 - "Major roadblocks limiting the development and effectiveness of new drugs to combat tuberculosis are the profound innate resistance of Mycobacterium tuberculosis to host defense mechanisms as well as its intrinsic tolerance to chemotherapeutic reagents. " 01/01/2009 - "Mycobacterial subversion of chemotherapeutic reagents and host defense tactics: challenges in tuberculosis drug development." Order ALL the reference details at left...
5.	Lymphoma (Lymphomas) 04/01/1986 - "A general application of immunophenotyping of malignant lymphomas in clinical hematology will depend on a better standardization of the immunological reagents, a simplification of logistic problems and a significant reduction of the costs." 06/01/1999 - "The discovery of KSHV in a subset of malignant lymphomas has allowed the development of lymphoma cell lines which now serve as biological reagents for propagating the virus, as a substrate for serologic assays, and as a model system for pathobiologic studies. " 12/01/1987 - "Its advantage lies in its sensitivity and greater B cell specificity than any of the B cell related reagents currently available for the study of malignant lymphoma in fixed tissues." 01/01/2005 - "We will highlight how improvements in our understanding of lymphoma biology rapidly facilitate the development of new diagnostic reagents that could be used to alter clinical practice. " 07/17/2003 - "These results raise the possibility that deregulated expression of BCL6 may endow lymphoma cells with resistance to chemotherapeutic reagents, most likely by enhancing the antioxidant defense systems." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Antigens
2.	Antibodies
3.	Vaccines
4.	Monoclonal Antibodies
5.	Peptides
6.	DNA (Deoxyribonucleic Acid)
7.	Penicillins (Penicillin)
8.	Paraffin
9.	Estrogens (Estrogen)
10.	Fluorescent Dyes (Fluorescent Probes)

Related Therapies and Procedures

1.	Immunotherapy
2.	Therapeutics
3.	Drug Therapy (Chemotherapy)
4.	Autologous Transplantation (Autograft)
5.	Heterologous Transplantation (Xenotransplantation)

Best Treatments:
Research Summary Report
on Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 20112 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>